Login USERNAME  PASSWORD  REMEMBER ME
Medical Malpractice Law & Strategy

Volume 26 - Number 10 | July 2009

July Issue in PDF Format


Off-Label Promotion of Drugs and Medical Devices
By Michael Kendall and Nicole Colby Longton
A spate of billion- and hundred-million-dollar settlements with the Department of Justice (DOJ) illustrates how the investigation of off-label promotions of drugs and devices has emerged as a predominant theory in pharmaceutical and medical-device prosecutions.

Stimulus Funds For Electronic Medical Record Systems
By Jonathan Bick
One of the newer ideas for reducing medical errors is to have medical providers use electronic medical record keeping methods. However, the single greatest inhibitor to taking advantage of technology is the requirement for an initial investment and, in the medical records technology area, this could be significant.

New Jersey’s Medical Error Reporting Law, And What It Will Accomplish
By John Ratkowitz
An examination of the reasons why health care providers fail to meet their ethical obligation to disclose errors can shed light on how mandatory error reporting will change malpractice litigation.

The HITECH Act And Health Care Attorneys
By Lee. S. Atckinson
President Barack Obama executed The American Recovery and Reinvestment Act of 2009 (the "Stimulus Act") on Feb. 17, 2009. The new legislation, while aimed at stimulating the economy and increasing patient safety, has another side that health law attorneys need to be aware of.

Med Mal News
The latest news you need to know.

Drug & Device News
Recent happenings of importance.

Verdicts
Recent rulings of importance to you and your practice.

Movers & Shakers
Who's doing what; who's going where.